These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 15810015)

  • 1. Detection and quantification of circulating tumor cells in mouse models of human breast cancer using immunomagnetic enrichment and multiparameter flow cytometry.
    Allan AL; Vantyghem SA; Tuck AB; Chambers AF; Chin-Yee IH; Keeney M
    Cytometry A; 2005 May; 65(1):4-14. PubMed ID: 15810015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of circulating tumor cells in breast cancer patients utilizing multiparameter flow cytometry and assessment of the prognosis of patients in different CTCs levels.
    Hu Y; Fan L; Zheng J; Cui R; Liu W; He Y; Li X; Huang S
    Cytometry A; 2010 Mar; 77(3):213-9. PubMed ID: 20169594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of tumor cell dissemination patterns in preclinical models of cancer metastasis using flow cytometry and laser scanning cytometry.
    Goodale D; Phay C; Postenka CO; Keeney M; Allan AL
    Cytometry A; 2009 Apr; 75(4):344-55. PubMed ID: 18855920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Detection and clinical significance of circulating tumor cells in peripheral blood of breast cancer patients].
    Cai QQ; Huang HQ; Lin TX; Jiang WQ
    Ai Zheng; 2005 Jul; 24(7):837-41. PubMed ID: 16004811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of circulating cytokeratin-positive cells in the blood of breast cancer patients using immunomagnetic enrichment and digital microscopy.
    Witzig TE; Bossy B; Kimlinger T; Roche PC; Ingle JN; Grant C; Donohue J; Suman VJ; Harrington D; Torre-Bueno J; Bauer KD
    Clin Cancer Res; 2002 May; 8(5):1085-91. PubMed ID: 12006523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of immunomagnetic cell enrichment in combination with RT-PCR for the detection of rare circulating head and neck tumor cells in human peripheral blood.
    Tong X; Yang L; Lang JC; Zborowski M; Chalmers JJ
    Cytometry B Clin Cytom; 2007 Sep; 72(5):310-23. PubMed ID: 17205568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical significance of cytokeratin 20-positive circulating tumor cells detected by a refined immunomagnetic enrichment assay in colorectal cancer patients.
    Wong SC; Chan CM; Ma BB; Hui EP; Ng SS; Lai PB; Cheung MT; Lo ES; Chan AK; Lam MY; Au TC; Chan AT
    Clin Cancer Res; 2009 Feb; 15(3):1005-12. PubMed ID: 19188172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular detection of telomerase-positive circulating epithelial cells in metastatic breast cancer patients.
    Soria JC; Gauthier LR; Raymond E; Granotier C; Morat L; Armand JP; Boussin FD; Sabatier L
    Clin Cancer Res; 1999 May; 5(5):971-5. PubMed ID: 10353728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. One-tube triple staining method for flow cytometric analysis of DNA ploidy and phenotypic heterogeneity of human solid tumors using single laser excitation.
    Corver WE; Bonsing BA; Abeln EC; Vlak-Theil PM; Cornelisse CJ; Fleuren GJ
    Cytometry; 1996 Dec; 25(4):358-66. PubMed ID: 8946143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A combined micromagnetic-microfluidic device for rapid capture and culture of rare circulating tumor cells.
    Kang JH; Krause S; Tobin H; Mammoto A; Kanapathipillai M; Ingber DE
    Lab Chip; 2012 Jun; 12(12):2175-81. PubMed ID: 22453808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An immunomagnetic epithelial tumor cell enrichment model for minimal residual disease detection of cytokeratin 8+ malignancies.
    Brooimans RA; de Leeuw N; Bontenbal M; Gratama JW
    J Biol Regul Homeost Agents; 2005; 19(1-2):84-91. PubMed ID: 16178280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of disease progression and poor overall survival with detection of circulating tumor cells in peripheral blood of patients with metastatic breast cancer.
    Bauernhofer T; Zenahlik S; Hofmann G; Balic M; Resel M; Pirchmoser R; Regitnig P; Ambros P; Dandachi N; Samonigg H
    Oncol Rep; 2005 Feb; 13(2):179-84. PubMed ID: 15643496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of rare circulating breast cancer cells by filtration cytometry and identification by DNA content: sensitivity in an experimental model.
    Rostagno P; Moll JL; Bisconte JC; Caldani C
    Anticancer Res; 1997; 17(4A):2481-5. PubMed ID: 9252667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of tumor cells in the bone marrow, peripheral blood, and apheresis products of breast cancer patients using flow cytometry.
    Simpson SJ; Vachula M; Kennedy MJ; Kaizer H; Coon JS; Ghalie R; Williams S; Van Epps D
    Exp Hematol; 1995 Sep; 23(10):1062-8. PubMed ID: 7544737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enrichment of rare cancer cells through depletion of normal cells using density and flow-through, immunomagnetic cell separation.
    Lara O; Tong X; Zborowski M; Chalmers JJ
    Exp Hematol; 2004 Oct; 32(10):891-904. PubMed ID: 15504544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simultaneous measurement of progesterone receptors and DNA indices by flow cytometry: characterization of an assay in breast cancer cell lines.
    Graham ML; Bunn PA; Jewett PB; Gonzalez-Aller C; Horwitz KB
    Cancer Res; 1989 Jul; 49(14):3934-42. PubMed ID: 2736533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of rare MCF-7 breast carcinoma cells from mixtures of human peripheral leukocytes by magnetic deposition analysis.
    Fang B; Zborowski M; Moore LR
    Cytometry; 1999 Aug; 36(4):294-302. PubMed ID: 10404144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunomagnetic quantification of circulating tumor cells as a prognostic factor of androgen deprivation responsiveness in patients with hormone naive metastatic prostate cancer.
    Okegawa T; Nutahara K; Higashihara E
    J Urol; 2008 Oct; 180(4):1342-7. PubMed ID: 18707699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enumeration, characterization, and collection of intact circulating tumor cells by cross contamination-free flow cytometry.
    Takao M; Takeda K
    Cytometry A; 2011 Feb; 79(2):107-17. PubMed ID: 21246706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bioluminescent human breast cancer cell lines that permit rapid and sensitive in vivo detection of mammary tumors and multiple metastases in immune deficient mice.
    Jenkins DE; Hornig YS; Oei Y; Dusich J; Purchio T
    Breast Cancer Res; 2005; 7(4):R444-54. PubMed ID: 15987449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.